Related references
Note: Only part of the references are listed.B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia
P. Kebriaei et al.
BONE MARROW TRANSPLANTATION (2006)
Rituximab for steroid-refractory chronic graft-versus-host disease
Corey Cutler et al.
BLOOD (2006)
Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ
BE Anderson et al.
BLOOD (2005)
Donor APCs are required for maximal GVHD but not for GVL
CC Matte et al.
NATURE MEDICINE (2004)
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
JCW Edwards et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
